You are here: Home: PCU 1 | 2006: Richard G Stock, MD: Select publications

SELECT PUBLICATIONS

Beyer DC et al. Relative influence of Gleason score and pretreatment PSA in predicting survival following brachytherapy for prostate cancer. Brachytherapy 2003;2(2):77-84. Abstract

Bolla M et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): A phase III randomised trial. Lancet 2002;360(9327):103-6. Abstract

D’Amico AV et al. 6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: A randomized controlled trial. JAMA 2004;292(7):821-7. Abstract

Feigenberg SJ et al. Health-related quality of life in men receiving prostate brachytherapy on RTOG 98-05. Int J Radiat Oncol Biol Phys 2005;62(4):956-64. Abstract

Finney G et al. Cross-sectional analysis of sexual function after prostate brachytherapy. Urology 2005;66(2):377-81. Abstract

Freedland SJ et al; SEARCH Database Study Group. Delay of radical prostatectomy and risk of biochemical progression in men with low risk prostate cancer. J Urol 2006;175(4):1298- 302. Abstract

Freedland SJ et al. Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: A search database study. J Clin Oncol 2005;23(30):7546-54. Abstract

Freedland SJ et al. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA 2005;294(4):433-9. Abstract

Freedland SJ et al. The prostatic specific antigen era is alive and well: Prostatic specific antigen and biochemical progression following radical prostatectomy. J Urol 2005;174(4 Pt 1):1276-81. Abstract

Hanks GE et al; Radiation Therapy Oncology Group. Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: The Radiation Therapy Oncology Group Protocol 92-02. J Clin Oncol 2003;21(21):3972-8. Abstract

Herstein A et al. I-125 versus Pd-103 for low-risk prostate cancer: Long-term morbidity outcomes from a prospective randomized multicenter controlled trial. Cancer J 2005;11(5):385-9. Abstract

Kollmeier MA et al. Biochemical outcomes after prostate brachytherapy with 5-year minimal follow-up: Importance of patient selection and implant quality. Int J Radiat Oncol Biol Phys 2003;57(3):645-53. Abstract

Langley S et al. European collaborative group on prostate brachytherapy: Preliminary report in 1175 patients. Eur Urol 2004;46(5):565-70. Abstract

Merrick GS et al. The impact of radiation dose to the urethra on brachytherapy-related dysuria. Brachytherapy 2005;4(1):45-50. Abstract

Millar JL et al. A simple technique for determining accurate urethral dosimetry after seed brachytherapy for prostate cancer. Brachytherapy 2006;5(1):27-31. Abstract

Sathya JR et al. Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate. J Clin Oncol 2005;23(6):1192-9. Abstract

Shah SA et al. Rectal complications after prostate brachytherapy. Dis Colon Rectum 2004;47(9):1487-92. Abstract

Stock RG et al. Disease-specific survival following the brachytherapy management of prostate cancer. Int J Radiat Oncol Biol Phys 2006a;64(3):810-6. Abstract

Stock RG et al. Biologically effective dose values for prostate brachytherapy: Effects on PSA failure and posttreatment biopsy results. Int J Radiat Oncol Biol Phys 2006b;64(2):527-33. Abstract

Stock RG et al. Combined modality treatment in the management of high-risk prostate cancer. Int J Radiat Oncol Biol Phys 2004;59(5):1352-9. Abstract

Stock RG et al. Penile erectile function after permanent radioactive seed implantation for treatment of prostate cancer. J Urol 2001;165(2):436-9. Abstract

Stone NN et al. Intermediate term biochemical-free progression and local control following 125iodine brachytherapy for prostate cancer. J Urol 2005;173(3):803-7. Abstract

Stone NN, Stock RG. Complications following permanent prostate brachytherapy. Eur Urol 2002;41(4):427-33. Abstract

Home